Can coronary artery bypass surgery provide equivalent outcomes after percutaneous coronary interventions?;Cirurgia de revascularização miocárdica após intervenção coronária percutânea. Podemos obter os mesmos resultados?

Brazilian Journal of Cardiovascular Surgery

Volumn 21, Issue 4, 2006, Pages

  Gomes, Walter J ^a   Buffolo, Enio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847671484     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S1678-97412006000400003     Document Type: Editorial

References (18)

1. Gomes WJ, Buffolo E. Coronary stenting and inflammation. Implications for further surgical and medical treatment. Ann Thorac Surg. 2006;81(5):1918-25.
2. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46(2):231-6.
3. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27(2):166-70.
4. Katritsis DG, Karvouni E, Ioannidis JPA. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol. 2005;95(5):640-3.
5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126-30.
6. Rodriguez AE, Mieres J, Fernandez-Pereira C, Vigo CF, Rodriguez-Alemparte M, Berrocal D, et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol. 2006;47(1):205-7.
7. Pfisterer ME, for the BASKET-LATE Investigators. BASKET-LATE: late clinical events related to late stent thrombosis after stopping clopidogrel: drug-eluting vs bare-metal stenting. In: American College of Cardiology 55th Annual Scientific Session. March 11 - 14, 2006;Atlanta.
8. Camenzind E. Safety of drug-eluting stents: a meta-analysis of first generation of drug-eluting stent programs. In: World Congress of Cardiology 2006; Sept. 2-6, 2006;Barcelona.
9. Nordmann AJ, Briel M, Bucher HC. Safety of drug-eluting stents: insights from a meta-analysis. In: World Congress of Cardiology 2006; Sept. 2-6, 2006;Barcelona.
10. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109(25):3171-5.
11. Gomes WJ, Giannotti-Filho O, Hossne NA Jr, Catani R, Buffolo E. Inflammatory reaction after sirolimus-eluting stent implant. Ann Thorac Surg. 2005;80:1903-4.
12. Kamiya H, Ushijima T, Mukai K, Ikeda C, Ueyama K, Watanabe G. Late patency of the internal thoracic artery graft in patients with and without previous successful percutaneous transluminal coronary angioplasty. Interact Cardiovasc Thorac Surg. 2004;3(1):110-3.
13. Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G, et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation. 2005;112(9 suppl):I-265-9.
14. Hassan A, Buth KJ, Baskett RJF, Ali IS, Maitland A, Sullivan JA, et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J. 2005;150(5):1026-31.
15. Thielmann M, Leyh R, Massoudy P, Neuhäuser M, Aleksic I, Kamler M, et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 2006;114(1 Suppl):I-441-7.
16. Fragomeni LSM, Falleiro RP, Hoppen G, Krahl G. Coronary artery bypass grafts in patients with coronary stents. Braz J Cardiovasc Surg. 2005;20(4):371-6.
17. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47(1):175-81.
18. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193-202.